Cas:1160270-44-9 Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate manufacturer & supplier

We serve Chemical Name:Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate CAS:1160270-44-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate

Chemical Name:Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate
CAS.NO:1160270-44-9
Synonyms:Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate
Molecular Formula:C20H15F3O4
Molecular Weight:376.32600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.76000
Exact Mass:376.09200
LogP:5.28770

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate Use and application,Ethyl 4-hydroxy-7-[4-(trifluoromethoxy)phenyl]-2-naphthoate technical grade,usp/ep/jp grade.


Related News: In the US, however, ODAC in April voted to keep alive the accelerated approval for Tecentriq plus Abraxane (nab-paclitaxel) in mTNBC while additional confirmatory trials are ongoing. 2,6-Difluoro-4-methylaniline manufacturers A panel of Israeli vaccination experts advising the health ministry overwhelmingly approved the booster campaign late on Wednesday, Bennett said. People over 60 who received their second dose of the Pfizer vaccine at least five months ago will be eligible. 1-(2-chloro-4-fluorophenyl)cyclopentane-1-carbonitrile suppliers The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. 4-tert-butyl-5-(hydroxymethyl)-1,2-dihydropyrazol-3-one vendor & factory.